Published in J Mol Biol on July 22, 2011
Glycosphingolipid-functionalized nanoparticles recapitulate CD169-dependent HIV-1 uptake and trafficking in dendritic cells. Nat Commun (2014) 0.87
Photothermal imaging and measurement of protein shell stoichiometry of single HIV-1 Gag virus-like nanoparticles. ACS Nano (2011) 0.84
A novel minimal in vitro system for analyzing HIV-1 Gag-mediated budding. J Biol Phys (2014) 0.78
RNA control of HIV-1 particle size polydispersity. PLoS One (2014) 0.78
A Method for Molecular Dynamics on Curved Surfaces. Biophys J (2016) 0.75
Faceted particles formed by the frustrated packing of anisotropic colloids on curved surfaces. Soft Matter (2016) 0.75
EMAN: semiautomated software for high-resolution single-particle reconstructions. J Struct Biol (1999) 27.52
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell (1996) 6.74
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science (1997) 6.10
The stoichiometry of Gag protein in HIV-1. Nat Struct Mol Biol (2004) 4.91
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A (1996) 4.83
Structure of the HIV-1 nucleocapsid protein bound to the SL3 psi-RNA recognition element. Science (1998) 4.52
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
The atomic structure of the bluetongue virus core. Nature (1998) 4.27
Structure of full-length HIV-1 CA: a model for the mature capsid lattice. Cell (2007) 4.25
Mechanisms of tryptophan fluorescence shifts in proteins. Biophys J (2001) 4.17
X-ray structures of the hexameric building block of the HIV capsid. Cell (2009) 4.08
The structural biology of HIV assembly. Curr Opin Struct Biol (2008) 3.71
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr Biol (1997) 3.59
Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol (1994) 3.56
Determination of size and concentration of gold nanoparticles from UV-vis spectra. Anal Chem (2007) 3.55
Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat Struct Biol (2002) 3.54
Mechanisms of enveloped RNA virus budding. Trends Cell Biol (2002) 3.36
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
Electron cryotomography of immature HIV-1 virions reveals the structure of the CA and SP1 Gag shells. EMBO J (2007) 3.17
NMR structure of the HIV-1 nucleocapsid protein bound to stem-loop SL2 of the psi-RNA packaging signal. Implications for genome recognition. J Mol Biol (2000) 2.89
Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem (2006) 2.86
A conformational switch controlling HIV-1 morphogenesis. EMBO J (2000) 2.86
Structure and assembly of turnip crinkle virus. II. Mechanism of reassembly in vitro. J Mol Biol (1986) 2.77
Structure and assembly of immature HIV. Proc Natl Acad Sci U S A (2009) 2.51
Organization of immature human immunodeficiency virus type 1. J Virol (2001) 2.34
A peptide inhibitor of HIV-1 assembly in vitro. Nat Struct Mol Biol (2005) 2.21
Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J Virol (1998) 2.14
Three-dimensional structure of HIV-1 virus-like particles by electron cryotomography. J Mol Biol (2004) 2.10
Modulation of HIV-like particle assembly in vitro by inositol phosphates. Proc Natl Acad Sci U S A (2001) 2.07
Human immunodeficiency virus type 1 matrix inhibits and confers cooperativity on gag precursor-membrane interactions. J Virol (2004) 1.94
Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell Host Microbe (2008) 1.91
Electrostatic origin of the genome packing in viruses. Proc Natl Acad Sci U S A (2006) 1.81
Viral self-assembly as a thermodynamic process. Phys Rev Lett (2003) 1.80
Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol (2007) 1.79
Interaction of gold nanoparticles with common human blood proteins. ACS Nano (2010) 1.74
A cell-penetrating helical peptide as a potential HIV-1 inhibitor. J Mol Biol (2008) 1.70
Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci U S A (2007) 1.66
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol (2006) 1.65
Packaging of a polymer by a viral capsid: the interplay between polymer length and capsid size. Biophys J (2007) 1.57
Deciphering the kinetic mechanism of spontaneous self-assembly of icosahedral capsids. Nano Lett (2007) 1.56
Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res (2006) 1.47
Maturation inhibitors: a new therapeutic class targets the virus structure. AIDS Rev (2007) 1.45
Quantum dot encapsulation in viral capsids. Nano Lett (2006) 1.31
The effect of nanometre-scale structure on interfacial energy. Nat Mater (2009) 1.29
Multiplexed DNA detection with biobarcoded nanoparticle probes. Angew Chem Int Ed Engl (2006) 1.05
Encapsidation of nanoparticles by red clover necrotic mosaic virus. J Am Chem Soc (2007) 1.04
Nonequilibirum assembly, retroviruses, and conical structures. Phys Rev Lett (2009) 1.01
Preparation of recombinant HIV-1 gag protein and assembly of virus-like particles in vitro. Methods Mol Biol (2009) 1.00
Curvature dependence of viral protein structures on encapsidated nanoemulsion droplets. ACS Nano (2008) 0.97
Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. Nano Lett (2007) 0.94
Synergistic effects of mutations and nanoparticle templating in the self-assembly of cowpea chlorotic mottle virus capsids. Nano Lett (2009) 0.90
Biggest virus molecular structure yet! Nat Struct Biol (1998) 0.76
High-throughput SHAPE analysis reveals structures in HIV-1 genomic RNA strongly conserved across distinct biological states. PLoS Biol (2008) 4.40
Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene (2003) 2.71
XMRV: a new virus in prostate cancer? Cancer Res (2010) 1.95
An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem (2009) 1.85
Interactions of HIV-1 Gag with assembly cofactors. Biochemistry (2006) 1.83
PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol (2003) 1.80
Selective and nonselective packaging of cellular RNAs in retrovirus particles. J Virol (2007) 1.79
The RIG-I-like receptor LGP2 recognizes the termini of double-stranded RNA. J Biol Chem (2009) 1.78
Structural and functional analyses of the human Toll-like receptor 3. Role of glycosylation. J Biol Chem (2006) 1.73
Core-controlled polymorphism in virus-like particles. Proc Natl Acad Sci U S A (2007) 1.66
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch. J Mol Biol (2006) 1.65
Conformation of the HIV-1 Gag protein in solution. J Mol Biol (2006) 1.59
Interactions of murine APOBEC3 and human APOBEC3G with murine leukemia viruses. J Virol (2008) 1.50
Nucleic acid binding and chaperone properties of HIV-1 Gag and nucleocapsid proteins. Nucleic Acids Res (2006) 1.47
Complex interactions of HIV-1 nucleocapsid protein with oligonucleotides. Nucleic Acids Res (2006) 1.47
Definition of a high-affinity Gag recognition structure mediating packaging of a retroviral RNA genome. Proc Natl Acad Sci U S A (2010) 1.46
Assembly properties of human immunodeficiency virus type 1 Gag-leucine zipper chimeras: implications for retrovirus assembly. J Virol (2008) 1.39
Mechanical properties of murine leukemia virus particles: effect of maturation. Biophys J (2006) 1.35
RNA-binding proteins that inhibit RNA virus infection. Proc Natl Acad Sci U S A (2007) 1.35
Late viral interference induced by transdominant Gag of an endogenous retrovirus. Proc Natl Acad Sci U S A (2004) 1.34
Nanoparticle-templated assembly of viral protein cages. Nano Lett (2006) 1.33
HIV-1 Gag extension: conformational changes require simultaneous interaction with membrane and nucleic acid. J Mol Biol (2010) 1.33
Murine T cells potently restrict human immunodeficiency virus infection. J Virol (2004) 1.32
Quantum dot encapsulation in viral capsids. Nano Lett (2006) 1.31
Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol (2003) 1.30
Self-assembled virus-like particles with magnetic cores. Nano Lett (2007) 1.28
mRNA molecules containing murine leukemia virus packaging signals are encapsidated as dimers. J Virol (2004) 1.28
Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J Virol (2002) 1.27
An unusual topological structure of the HIV-1 Rev response element. Cell (2013) 1.26
Role of murine leukemia virus nucleocapsid protein in virus assembly. J Virol (2004) 1.22
Identification of replication competent murine gammaretroviruses in commonly used prostate cancer cell lines. PLoS One (2011) 1.22
Hoxb7 inhibits transgenic HER-2/neu-induced mouse mammary tumor onset but promotes progression and lung metastasis. Cancer Res (2008) 1.20
Diverse interactions of retroviral Gag proteins with RNAs. Trends Biochem Sci (2011) 1.18
Stimulation of hepatitis C virus (HCV) nonstructural protein 3 (NS3) helicase activity by the NS3 protease domain and by HCV RNA-dependent RNA polymerase. J Virol (2005) 1.18
RNA aptamers directed to human immunodeficiency virus type 1 Gag polyprotein bind to the matrix and nucleocapsid domains and inhibit virus production. J Virol (2010) 1.18
On the role of the SP1 domain in HIV-1 particle assembly: a molecular switch? J Virol (2011) 1.17
Time-resolved spectroscopic studies of the AppA blue-light receptor BLUF domain from Rhodobacter sphaeroides. Biochemistry (2005) 1.15
Mutational analysis of the SARS virus Nsp15 endoribonuclease: identification of residues affecting hexamer formation. J Mol Biol (2005) 1.15
Biochemical and biological studies of mouse APOBEC3. J Virol (2014) 1.14
Murine leukemia virus nucleocapsid mutant particles lacking viral RNA encapsidate ribosomes. J Virol (2002) 1.12
Effects of blocking individual maturation cleavages in murine leukemia virus gag. J Virol (2004) 1.12
Structural insight into the mechanism of activation of the Toll receptor by the dimeric ligand Spätzle. J Biol Chem (2008) 1.12
Role of surface charge density in nanoparticle-templated assembly of bromovirus protein cages. ACS Nano (2010) 1.12
In vitro characterization of the interaction between HIV-1 Gag and human lysyl-tRNA synthetase. J Biol Chem (2006) 1.09
XMRV and prostate cancer--a 'final' perspective. Nat Rev Urol (2012) 1.08
LL37 and cationic peptides enhance TLR3 signaling by viral double-stranded RNAs. PLoS One (2011) 1.08
Matrix domain modulates HIV-1 Gag's nucleic acid chaperone activity via inositol phosphate binding. J Virol (2010) 1.06
Hydrophilization of Magnetic Nanoparticles with Modified Alternating Copolymers. Part 1: The Influence of the Grafting. J Phys Chem C Nanomater Interfaces (2010) 1.05
An examination of the electrostatic interactions between the N-terminal tail of the Brome Mosaic Virus coat protein and encapsidated RNAs. J Mol Biol (2012) 1.04
Fundamental differences between the nucleic acid chaperone activities of HIV-1 nucleocapsid protein and Gag or Gag-derived proteins: biological implications. Virology (2010) 1.01
Reversible binding of recombinant human immunodeficiency virus type 1 gag protein to nucleic acids in virus-like particle assembly in vitro. J Virol (2002) 1.01
Preparation of recombinant HIV-1 gag protein and assembly of virus-like particles in vitro. Methods Mol Biol (2009) 1.00
Hydrophilic Monodisperse Magnetic Nanoparticles Protected by an Amphiphilic Alternating Copolymer. J Phys Chem C Nanomater Interfaces (2008) 1.00
Bio-enabled synthesis of metamaterials. Annu Rev Phys Chem (2010) 1.00
Packaging of gold particles in viral capsids. J Nanosci Nanotechnol (2005) 0.98
Electrostatic interactions and binding orientation of HIV-1 matrix studied by neutron reflectivity. Biophys J (2010) 0.97
cis- and trans-acting functions of brome mosaic virus protein 1a in genomic RNA1 replication. J Virol (2007) 0.96
Self-assembly approaches to nanomaterial encapsulation in viral protein cages. J Mater Chem (2008) 0.95
Identification of HIV-1 nucleocapsid protein: nucleic acid antagonists with cellular anti-HIV activity. Biochem Biophys Res Commun (2002) 0.95
Hydrophilization of Magnetic Nanoparticles with Modified Alternating Copolymers. Part 2: Behavior in solution. J Phys Chem C Nanomater Interfaces (2010) 0.94
Encapsidation and transduction of cellular genes by retroviruses. Front Biosci (2003) 0.94
Core-like particles of an enveloped animal virus can self-assemble efficiently on artificial templates. Nano Lett (2007) 0.94
Enzymatic activities of the GB virus-B RNA-dependent RNA polymerase. Virology (2003) 0.93
Functional redundancy in HIV-1 viral particle assembly. J Virol (2012) 0.92
Take two. Nat Struct Mol Biol (2004) 0.92
Studies on the restriction of murine leukemia viruses by mouse APOBEC3. PLoS One (2012) 0.92
Synergistic effects of mutations and nanoparticle templating in the self-assembly of cowpea chlorotic mottle virus capsids. Nano Lett (2009) 0.90
The coat protein leads the way: an update on basic and applied studies with the Brome mosaic virus coat protein. Mol Plant Pathol (2010) 0.90
Self-assembly of brome mosaic virus capsids: insights from shorter time-scale experiments. J Phys Chem A (2008) 0.89
Elements in HIV-1 Gag contributing to virus particle assembly. Virus Res (2012) 0.89
Effects of amino-acid substitutions in the Brome mosaic virus capsid protein on RNA encapsidation. Mol Plant Microbe Interact (2010) 0.88
Magnetic virus-like nanoparticles in N. benthamiana plants: a new paradigm for environmental and agronomic biotechnological research. ACS Nano (2011) 0.87
A conformational transition observed in single HIV-1 Gag molecules during in vitro assembly of virus-like particles. J Virol (2014) 0.86
Slow hot-carrier relaxation in colloidal graphene quantum dots. Nano Lett (2010) 0.86
Preliminary physical mapping of RNA-RNA linkages in the genomic RNA of Moloney murine leukemia virus. J Virol (2005) 0.85
The tripartite virions of the brome mosaic virus have distinct physical properties that affect the timing of the infection process. J Virol (2014) 0.85
Physiochemical properties of Caulobacter crescentus holdfast: a localized bacterial adhesive. J Phys Chem B (2013) 0.84
Photothermal imaging and measurement of protein shell stoichiometry of single HIV-1 Gag virus-like nanoparticles. ACS Nano (2011) 0.84
Microfluidic devices integrating microcavity surface-plasmon-resonance sensors: glucose oxidase binding-activity detection. Anal Chem (2010) 0.84
Stable RNA structures can repress RNA synthesis in vitro by the brome mosaic virus replicase. RNA (2003) 0.83
Solution properties of murine leukemia virus gag protein: differences from HIV-1 gag. J Virol (2011) 0.82
Fusion of mApple and Venus fluorescent proteins to the Sindbis virus E2 protein leads to different cell-binding properties. Virus Res (2013) 0.82
Bio-inspired materials: unnatural life. Nat Mater (2008) 0.81
An immature retroviral RNA genome resembles a kinetically trapped intermediate state. J Virol (2014) 0.80
The packaging of different cargo into enveloped viral nanoparticles. Mol Pharm (2012) 0.80
Magnetic nanoparticles with functional silanes: evolution of well-defined shells from anhydride containing silane. J Mater Chem (2009) 0.79
Measuring the binding stoichiometry of HIV-1 Gag to very-low-density oligonucleotide surfaces using surface plasmon resonance spectroscopy. J Biomol Tech (2007) 0.79